MetaCap

Envista Financial Ratios

NYSE: NVSTHealth CareMedical/Dental InstrumentsUSD

23.00+0.28 (+1.23%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Envista ratio analysis

Envista earned a net margin of 1.7% in FY 2025, up from -44.6% a year earlier. Gross margin was 54.7% compared with a median of 56.6% over the prior 8 years. Return on equity reached 1.5%, meaning Envista generated 0.02 dollars of profit for every dollar of shareholders' equity.

Debt-to-equity stood at 0.47 versus 0.48 the year before, and the current ratio was 2.38. At the end of FY 2025, NVST traded at 77.5 times earnings; across the 5 fiscal years shown, its year-end P/E ranged from 19.0 to 168.6, with a median of 24.6. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

Envista financial ratios (annual)

Envista annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
P/E ratio (at fiscal year end)77.46——24.5823.47168.6519.04——
Price / sales1.341.311.562.132.902.791.82——
Price / book1.171.120.961.301.791.451.17——
Gross margin54.7%54.7%56.1%57.4%56.9%54.7%59.1%56.3%57.7%
Operating margin7.9%-41.4%1.2%12.4%12.2%2.3%10.3%10.5%13.8%
Net margin1.7%-44.6%-3.9%9.5%13.6%1.7%9.5%8.1%10.7%
Free cash flow margin8.5%12.1%8.5%4.2%12.2%12.2%14.0%11.5%11.0%
Return on equity (ROE)1.5%-38.1%-2.4%5.8%8.4%0.9%6.1%4.8%—
Return on assets (ROA)0.8%-20.9%-1.5%3.7%5.2%0.5%3.5%3.9%5.0%
Debt / equity0.470.480.360.330.320.480.370.00—
Current ratio2.382.042.231.151.520.941.411.23—
Revenue growth8.3%-2.2%-0.1%2.4%30.1%-15.6%-19.7%1.2%—
EPS growth——-143.8%-28.6%860.0%-87.5%-11.1%-23.4%—

Related